Product Information
PIRFENIDONE 267 MG CAPSULE is a generic product labeled by Cipla USA Inc., priced at $1.6515 per EA under NDC 69097094093. Its NADAC has been published 78 times since Dec 18, 2024.
FDA first approved this application on Aug 1, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
267 mg/1
Manufacturer
Cipla USA Inc.NDC
69097094093
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
6/18/2025
Active Ingredients
PIRFENIDONEApproval Type
Generic (ANDA)
FDA Application
ANDA212077FDA Approved
8/1/2022
TE Code
AB
On Market Since
8/2/2022
Pharmacological Classes
Price Statistics
The NADAC for PIRFENIDONE 267 MG CAPSULE has been published 78 times since Dec 18, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.6515 per EA |
|---|---|
| All-time high | $1.6651 (Mar 12, 2025) |
| All-time low | $1.6515 (Mar 19, 2025) |
| 52-week high | $1.6515 |
| 52-week low | $1.6515 |
| Median price | $1.6515 |
| Average price | $1.6538 |
| Largest weekly change | -0.8% (Mar 19, 2025) |
| Weeks tracked | 78 |
| Tracking since | Dec 18, 2024 |
1W
N/A
1M
N/A
3M
0.0%
6M
0.0%
1Y
0.0%
3Y
N/A
5Y
N/A
All
-0.8%
Last surveyed Jun 10, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of PIRFENIDONE 267 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for PIRFENIDONE 267 MG CAPSULE, manufactured by Cipla USA Inc., is $1.6515 per EA (NDC 69097094093), effective Jun 10, 2026.
How has the price of PIRFENIDONE 267 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for PIRFENIDONE 267 MG CAPSULE has held within roughly two percent of its current level. It has been tracked across 78 weekly CMS publications since Dec 18, 2024.
What are the highest and lowest recorded NADAC prices for PIRFENIDONE 267 MG CAPSULE?
Since Dec 18, 2024, the NADAC for PIRFENIDONE 267 MG CAPSULE has ranged from a low of $1.6515 (Mar 19, 2025) to a high of $1.6651 (Mar 12, 2025), with a median of $1.6515 per EA.
Are there cheaper alternatives to PIRFENIDONE 267 MG CAPSULE?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as PIRFENIDONE 267 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures PIRFENIDONE 267 MG CAPSULE?
PIRFENIDONE 267 MG CAPSULE (NDC 69097094093) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.